论文信息 - ASO Author Reflections: Thirty Years of Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at Wake Forest University - 字舞流文

ASO Author Reflections: Thirty Years of Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at Wake Forest University

E. Levine | P. Shen | C. Valenzuela | K. Votanopoulos

[1] E. Levine,et al. Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Cancers with Peritoneal Metastasis: A 30-year Institutional Experience , 2022, Annals of Surgical Oncology.

[2] E. Levine,et al. Timing of Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Recurrent Low-Grade Appendiceal Mucinous Neoplasms , 2022, Annals of Surgical Oncology.

[3] D. Morris,et al. Long‐term survival outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy: Single‐institutional experience with 1225 cases , 2019, Journal of surgical oncology.

[4] D. Bartlett,et al. A Multicenter Randomized Trial to Evaluate Hematologic Toxicities after Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin or Mitomycin in Patients with Appendiceal Tumors. , 2018, Journal of the American College of Surgeons.

[5] P. Sugarbaker. Surgical management of peritoneal carcinosis: Diagnosis, prevention and treatment , 2005, Langenbecks Archiv für Chirurgie.

[6] J. Spratt,et al. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. , 1980, Cancer research.